The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.
The importance of T cell-mediated immunity for resistance to the disease (cryptococcal disease) caused by Cryptococcus neoformans is incontrovertible, but whether Ab immunity also contributes to resistance remains uncertain. To investigate the role of IgM in resistance to C. neoformans, we compared the survival, fungal burden, lung and brain inflammatory responses, and lung phagocytic response of sIgM(-/-) mice, which lack secreted IgM, to that of IgM sufficient C57BL6x129Sv (heretofore, control) mice at different times after intranasal infection with C. neoformans (24067). sIgM(-/-) mice had higher mortality and higher blood and brain CFUs 28 d postinfection, but lung CFUs were comparable. Lungs of control mice manifested exuberant histiocytic inflammation with visible C. neoformans, findings that were not observed in sIgM(-/-) mice, whereas in brain sections, sIgM(-/-) mice had marked inflammation with visible C. neoformans that was not observed in control mice. Cytokine responses were significant for higher levels of lung IL-1beta and IL-12 24 h postinfection in control mice and higher levels of lung and brain IL-17 28 d postinfection in sIgM(-/-) mice. Alveolar macrophage phagocytosis was significantly higher for control than for sIgM(-/-) mice 24 h postinfection; however, phagocytic indices of sIgM(-/-) mice increased after reconstitution of sIgM(-/-) mice with polyclonal IgM. These data establish a previously unrecognized role for IgM in resistance to intranasal infection with C. neoformans in mice and suggest that the mechanism by which it mediates a host benefit is by augmenting Th1 polarization, macrophage recruitment and phagocytosis of C. neoformans.
Subramaniam
Krishanthi S
KS
Department of Microbiology and Immunology, Albert Einstein College of Medicine of the Yeshiva University, Bronx, NY 10461, USA.
Datta
Kausik
K
Quintero
Eric
E
Manix
Catherine
C
Marks
Matthew S
MS
Pirofski
Liise-Anne
LA
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood* / Q000235:genetics; D003453:Cryptococcosis / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D003455:Cryptococcus neoformans / Q000276:immunology*; D020022:Genetic Predisposition to Disease; D007075:Immunoglobulin M / Q000097:blood / Q000172:deficiency* / Q000235:genetics; D008168:Lung / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D008172:Lung Diseases, Fungal / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D015854:Up-Regulation / Q000235:genetics / Q000276:immunology
D000907:Antibodies, Bacterial; D007075:Immunoglobulin M
Clin Exp Immunol. 2010 Jan;159(1):100-8
19843088
Infect Immun. 2010 Mar;78(3):1049-57
20048044
Infect Immun. 2004 Aug;72(8):4810-8
15271943
PLoS One. 2008 Aug 06;3(8):e2870
18682846
J Virol. 2003 Feb;77(4):2578-86
12551996
Eukaryot Cell. 2007 Jan;6(1):48-59
17114598
Infect Immun. 2007 Nov;75(11):5085-94
17606600
Immunity. 2005 Jul;23(1):7-18
16039575
Infect Immun. 2002 Jun;70(6):2959-64
12010985
J Infect Dis. 1999 Sep;180(3):915-9
10438394
Infect Immun. 1994 Jul;62(7):2857-64
8005676
Clin Vaccine Immunol. 2006 Jul;13(7):740-6
16829610
Am J Pathol. 2009 Dec;175(6):2489-500
19893050
J Infect Dis. 1998 Oct;178(4):1213-6
9806064
Infect Immun. 1993 Dec;61(12):5302-8
7901167
Pediatrics. 2001 May;107(5):E66
11331716
Sabouraudia. 1985 Jun;23(3):225-34
4023888
Clin Vaccine Immunol. 2008 Feb;15(2):182-93
18032593
J Exp Med. 1992 Jun 1;175(6):1685-95
1588288
Nat Med. 2007 Oct;13(10):1173-5
17828272
J Clin Invest. 2006 Mar;116(3):783-96
16511606
Trends Immunol. 2003 Sep;24(9):474-8
12967670
Infect Immun. 2009 Aug;77(8):3450-7
19487474
J Leukoc Biol. 1994 Jan;55(1):35-42
7904293
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2250-5
10051627
Infect Immun. 2009 Jan;77(1):120-7
18936186
Infect Immun. 2001 May;69(5):3398-409
11292763
Infect Immun. 2007 Apr;75(4):1586-97
17296760
Springer Semin Immunopathol. 2005 Mar;26(4):347-62
15633017
Infect Immun. 2004 Sep;72(9):4985-95
15321990
J Immunol. 2000 Aug 1;165(3):1588-98
10903768
J Infect Dis. 2006 Apr 15;193(8):1178-86
16544260
Immunology. 2004 Nov;113(3):348-54
15500621
J Infect Dis. 2009 Jul 15;200(2):244-51
19527168
J Immunol. 2006 Jan 15;176(2):1098-106
16393998
Infect Immun. 2005 Feb;73(2):1141-50
15664957
Clin Exp Immunol. 1989 Dec;78(3):412-7
2612053
Immunobiology. 2009;214(8):664-73
19321225
Infect Immun. 2002 Mar;70(3):1571-80
11854246
Annu Rev Immunol. 2005;23:821-52
15771587
Clin Vaccine Immunol. 2008 Aug;15(8):1176-87
18524882
Immunol Rev. 2004 Feb;197:51-9
14962186
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16969-74
12477926
J Immunol. 2005 Aug 1;175(3):1827-33
16034125
J Immunol. 2007 Oct 15;179(8):5367-77
17911623
J Exp Med. 1998 Dec 21;188(12):2381-6
9858525
Ann N Y Acad Sci. 1992 May 4;651:182-99
1376039
FEMS Yeast Res. 2006 Jun;6(4):525-36
16696648
Immunol Rev. 2004 Feb;197:179-91
14962195
Am J Respir Cell Mol Biol. 1995 Oct;13(4):487-95
7546779
J Immunol. 2002 Apr 1;168(7):3419-27
11907100
Infect Immun. 2007 Oct;75(10):4792-8
17664261
FASEB J. 2010 Jun;24(6):1682-8
20065106
J Virol. 2007 Apr;81(7):3487-94
17202212
Clin Exp Immunol. 1995 Mar;99(3):425-32
7882565
Infect Immun. 2006 Oct;74(10):5977-88
16988277
J Immunol. 2006 Sep 1;177(5):2749-54
16920907
J Exp Med. 2002 Nov 18;196(10):1277-90
12438420
Infect Immun. 2002 May;70(5):2598-604
11953401
Immunity. 2005 Apr;22(4):415-26
15845447
J Exp Med. 2000 Jul 17;192(2):271-80
10899913
Clin Diagn Lab Immunol. 2005 Oct;12(10):1168-76
16210479
Am J Pathol. 2010 Feb;176(2):774-85
20056835
Eur J Immunol. 1992 Mar;22(3):711-7
1547817
J Infect Dis. 1999 Nov;180(5):1526-35
10515812
Int Immunol. 2001 Sep;13(9):1193-201
11526100
J Immunol. 2005 Sep 1;175(5):3244-51
16116215
J Exp Med. 2003 Apr 7;197(7):939-45
12682112
J Exp Med. 2008 Dec 22;205(13):3053-64
19075288
J Clin Microbiol. 1999 Oct;37(10):3204-9
10488178
Infect Immun. 2010 Jan;78(1):441-52
19901068
Blood. 2009 Jul 30;114(5):1005-15
19491392
Med Mycol. 2005 Feb;43(1):27-38
15712606
J Clin Invest. 2003 Oct;112(7):1080-94
14523045
J Immunol. 2007 Jun 15;178(12):8212-20
17548660
Infect Immun. 1992 Nov;60(11):4534-41
1398966
J Immunol. 1998 May 15;160(10):4776-87
9590224
Infect Immun. 1992 Oct;60(10):4080-7
1398921
J Immunol. 2005 Sep 1;175(5):3262-7
16116217
Infect Immun. 2008 Oct;76(10):4745-56
18678664
J Immunol. 2003 Apr 1;170(7):3819-27
12646649
Infect Immun. 2007 Jun;75(6):2729-39
17371865
Nat Med. 2006 Jun;12(6):682-7
16715088
J Leukoc Biol. 2006 Jul;80(1):36-44
16670124